Influenza A Virus H1N1 New Caledonia 20/99 IV 116

Products_type

Native Protein
Products_short_name

[Influenza A Virus H1N1 New Caledonia 20/99 IV 116]
Products_name_syn

[H1N1 New Caledonia; H1N1 Influenza-A Virus New Caledonia/20/99 IVR 116; Caledonia 20/99]
Purity

Greater than 90.0% as determined by ELISA analysis.
Form

Sterile Filtered colorless solution FormulationThe H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Storage_stability

A/New Caledonia/20/99 IVR although stable 4 degree C for 4 weeks, should be stored desiccated below -18 degree C. Please prevent freeze-thaw cycles.
Description

Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.